MAYNE RECEIVES $1.5 BILLION TAKE-OVER BID

The Australian Financial Review newspaper, earlier this week, reported that Melbourne-based pharmaceuticals manufacturer Mayne Pharma Ltd. has received an over $1.5 billion takeover approach from an international rival, on Wednesday. BioSpectrum (http://www.biospectrumasia.com/content/200906AUS1674.asp)